Lucas Ward
Stock Analyst at Ascendiant Capital
(0.52)
# 3,884
Out of 4,749 analysts
14
Total ratings
28.57%
Success rate
-42.99%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACON Aclarion | Maintains: Buy | $1.5 → $1.3 | $7.10 | -81.69% | 3 | Nov 27, 2024 | |
| LIQT LiqTech International | Maintains: Buy | $5.15 → $3.2 | $1.75 | +82.86% | 3 | Nov 25, 2024 | |
| VVOS Vivos Therapeutics | Reiterates: Buy | $6.6 | $3.97 | +66.25% | 2 | Nov 20, 2024 | |
| HSCS HeartSciences | Reiterates: Buy | $15 | $3.23 | +364.73% | 1 | Sep 23, 2024 | |
| CYTH Cyclo Therapeutics | Maintains: Buy | $2.6 → $0.95 | $0.77 | +23.38% | 2 | Aug 26, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $338 → $270 | $1.28 | +20,993.75% | 2 | Jul 29, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $29 | $0.73 | +3,865.30% | 1 | Oct 2, 2023 |
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $1.5 → $1.3
Current: $7.10
Upside: -81.69%
LiqTech International
Nov 25, 2024
Maintains: Buy
Price Target: $5.15 → $3.2
Current: $1.75
Upside: +82.86%
Vivos Therapeutics
Nov 20, 2024
Reiterates: Buy
Price Target: $6.6
Current: $3.97
Upside: +66.25%
HeartSciences
Sep 23, 2024
Reiterates: Buy
Price Target: $15
Current: $3.23
Upside: +364.73%
Cyclo Therapeutics
Aug 26, 2024
Maintains: Buy
Price Target: $2.6 → $0.95
Current: $0.77
Upside: +23.38%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $338 → $270
Current: $1.28
Upside: +20,993.75%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $29
Current: $0.73
Upside: +3,865.30%